Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A Cost Comparison of Infliximab Versus Intravenous Immunoglobulin for Refractory Kawasaki Disease Treatment
PaperCitations, authors & open-access status
A Cost Comparison of Infliximab Versus Intravenous Immunoglobulin for Refractory Kawasaki Disease Treatment is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 17 citations, 2021 year and green oa status.
17
Citations
2021
Year
green
OA Status